C. difficile is a bacterium that causes diarrhea and sometimes can lead to serious intestinal conditions or complications.

Valneva’s unpartnered Clostridium difficile┬ácandidate – VLA84

  • Valneva is developing VLA84, a vaccine candidate against Clostridium difficile, a leading cause of life threatening, healthcare associated infections worldwide.
  • Valneva completed Phase 2 development of its prophylactic vaccine candidate against Clostridium difficile infection.
  • VLA84 is currently Phase 3-ready and Valneva seeks to partner it.

 

Additional information about Clostridium difficile: